Potassium%25252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing Dosing is highly individualized based on serum potassium levels, clinical status, and presence of ECG changes. Local protocols or physician orders should be followed. **Oral:** * **Prevention:** Typically 20-40 mEq per day, divided into 1-2 doses. * **Treatment:** 40-100 mEq per day, divided into 2-4 doses. Maximum daily dose generally not to exceed 120 mEq/day without close monitoring. * **Severe Hypokalemia (serum K < 2.5 mEq/L):** May require higher doses, up to 200 mEq/day, administered orally or intravenously, under strict monitoring. **Intravenous (IV):** * **Continuous IV Infusion:** * **Concentration:** Typically infused at a concentration no greater than 40 mEq/L in non-critically ill patients to minimize phlebitis. Higher concentrations (up to 80-100 mEq/L) may be used in critical care settings with central venous access and continuous cardiac monitoring. * **Rate:** Generally no faster than 10-20 mEq/hour for peripheral IV. Rates up to 40 mEq/hour may be used in critical care with central access and continuous cardiac monitoring. * **Maximum Daily Dose:** Not established, but aggressive repletion should be guided by frequent serum potassium monitoring and clinical response. Daily doses can exceed 200 mEq in severe cases. ## Pediatric Dosing Dosing is highly individualized and often guided by weight and serum potassium levels. Local protocols should be followed. **Oral:** * **Prevention:** 1-2 mEq/kg/day, maximum 40 mEq/day. * **Treatment:** 2-5 mEq/kg/day, divided into 2-4 doses, maximum 100 mEq/day. **Intravenous (IV):** * **Concentration:** Typically not to exceed 40 mEq/L. * **Rate:** Generally no faster than 0.5-1 mEq/kg/hour, maximum 20 mEq/hour, unless in a critical care setting with continuous cardiac monitoring. * **Maximum Daily Dose:** Not established, but aggressive repletion should be guided by frequent serum potassium monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Potassium excretion is reduced, increasing the risk of hyperkalemia. Dosing should be significantly reduced and serum potassium closely monitored. ## Contraindications * Hyperkalemia. * Conditions which may predispose to hyperkalemia, such as untreated Addison's disease, certain types of renal failure, and immediately post-operative period in certain patients. * Certain instances of crush syndrome or extensive tissue injury. ## Adverse Effects * **Most Common:** Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal pain), particularly with oral administration. * **Serious:** Hyperkalemia (especially with rapid IV infusion, renal impairment, or excessive dosing). Symptoms include muscle weakness, fatigue, paresthesias, arrhythmias, cardiac arrest. * **IV Administration:** Phlebitis, venous irritation, pain at injection site. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Can cause hyperkalemia, especially in patients with renal impairment. * **NSAIDs:** May reduce the antihypertensive and diuretic effects and increase serum potassium levels. * **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can increase digoxin toxicity. ## Monitoring * **Serum Potassium:** Frequent monitoring is essential, especially with IV administration, high doses, renal impairment, or rapid correction. * **Renal Function (BUN, Creatinine):** To assess the ability to excrete potassium. * **ECG:** To assess for signs of hyperkalemia (e.g., peaked T waves, prolonged QRS). * **Urine Output:** Especially important in IV therapy. * **Signs and Symptoms of Hypokalemia and Hyperkalemia.** ## Clinical Pearls * Oral potassium chloride should be taken with meals or a full glass of fluid to minimize gastrointestinal irritation. * Liquid formulations may be preferred for easier dose titration and administration in pediatric patients. * Dilute IV potassium chloride appropriately to reduce the risk of phlebitis and local tissue damage. Never administer IV potassium chloride as a direct bolus injection. * The goal of therapy is to restore serum potassium to the normal range while avoiding iatrogenic hyperkalemia. *** *This information is intended for clinical decision-making and does not replace a thorough review of the official prescribing information or consultation with a prescriber or pharmacist. Always verify current prescribing information for the most up-to-date details on dosing, safety, and indications.*